$15M
Qualified
maximum offering price, as qualified
$923K
Reported Sold
1-K 2021-04-29
3
Filings
across 2 offerings
Equity Classes
| Type | Class | Outstanding |
|---|---|---|
| common | Common Stock | 88,647,425 |
Service Providers
| Role | Provider | CRD |
|---|---|---|
| auditor | Dannible & McKee, LLP | — |
| legal | CrowdCheck Law LLP | — |
| underwriter | North Capital Private Securities Corporation | 154559 |
Offerings
| File Number | Filings | First Filed | Last Filed | Qualified | Commenced | Price/Security | Securities Offered | Securities Sold | Qualified Sold | Outstanding | Aggregate Offering | Proceeds Reported | Estimated Net | Supplements | Last Supplement | CRD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 024-11155 | 2 | 2020-02-14 | 2021-04-29 | 2020-03-09 | 2020-03-09 | $3.00 | 5,000,000 | 307,769 | 5,000,000 | 88,647,425 | $15M | $923K | $707K | 4 | 2020-07-27 | 154559 |
The statements and reported figures behind Quadrant Biosciences Inc
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
External link: SEC Filings